Synthetic data for privacy-preserving clinical risk prediction

Synthetic data promise privacy-preserving data sharing for healthcare research and development. Compared with other privacy-enhancing approaches-such as federated learning-analyses performed on synthetic data can be applied downstream without modification, such that synthetic data can act in place of real data for a wide range of use cases. However, the role that synthetic data might play in all aspects of clinical model development remains unknown. In this work, we used state-of-the-art generators explicitly designed for privacy preservation to create a synthetic version of ever-smokers in the UK Biobank before building prognostic models for lung cancer under several data release assumptions. We demonstrate that synthetic data can be effectively used throughout the medical prognostic modeling pipeline even without eventual access to the real data. Furthermore, we show the implications of different data release approaches on how synthetic biobank data could be deployed within the healthcare system.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2024-10-27
DOI
https://doi.org/10.1038/s41598-024-72894-y
Citations
30
Primary Topic
Privacy-Preserving Technologies in Data
Type
article
Field-Weighted Citation Impact
10.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Synthetic data for privacy-preserving clinical risk prediction

Mihaela van der Schaar, Neal Navani, Bogdan Cebere, Zhaozhi Qian et al.
30 citations
Scientific Reports
Privacy-Preserving Technologies in Data
10.42
article

Synthetic data for privacy-preserving clinical risk prediction

Mihaela van der Schaar, Neal Navani, Bogdan Cebere, Zhaozhi Qian, Thomas Callender, Sam M. Janes
article en
30 citations

Abstract

Synthetic data promise privacy-preserving data sharing for healthcare research and development. Compared with other privacy-enhancing approaches-such as federated learning-analyses performed on synthetic data can be applied downstream without modification, such that synthetic data can act in place of real data for a wide range of use cases. However, the role that synthetic data might play in all aspects of clinical model development remains unknown. In this work, we used state-of-the-art generators explicitly designed for privacy preservation to create a synthetic version of ever-smokers in the UK Biobank before building prognostic models for lung cancer under several data release assumptions. We demonstrate that synthetic data can be effectively used throughout the medical prognostic modeling pipeline even without eventual access to the real data. Furthermore, we show the implications of different data release approaches on how synthetic biobank data could be deployed within the healthcare system.

Scientific ReportsVol. 14(1)
Turing Institute (GB), University of Cambridge (GB), University College London (GB)
Health and Care Research Wales, Cancer Research UK, Medical Research Council
Openalex Percentile: Top 1%
Privacy-Preserving Technologies in Data
10.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.